Surely with the Sumitomo interest as well as Fuji, State Path and China Resources are hovering in the background?
They were clear about their intentions in the newspapers, and have yet to do a deal with anyone else in this sector in Australia.
So that leaves only us.
China continues to be a big fan of 'natural' medicines, and you can't get more natural than using the body's own medicine secreting cells.
I wonder how much the GvHD Licence is worth to the Chinese?
Other companies which also could be doing a bit of hovering - maybe Astellas, Takeda, Hitachi, and possibly more likely Bayer? Hopefully they're getting the call.
BOD - please just reject this derisory bid and get on with making value rather than gifts!
Surely with the Sumitomo interest as well as Fuji, State Path...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $52.99M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.5¢ | 27.5¢ | $29.94K | 106.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 10159 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |